Lea Zillich
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (16)
Year:
2026
Year:
2026
Year:
2026
Stress plays a significant role in the development of mental and somatic disorders by dysregulating the hypothalamic-pituitary-adrenal (HPA) axis. Epigenetic mechanisms, particularly DNA methylation (DNAm), are assumed to mediate this relationship, with increasing evidence linking stress experience to DNAm changes, though the longitudinal effects of acute stress remain unclear. Here, 122 healthy individuals underwent the Maastricht Acute Stress Test (MAST). Salivary samples for cortisol measurements were taken at seven time points from before to 45 min after stress induction, and blood was drawn for DNAm analyses before and 45 min after. Cortisol reactivity was predicted by baseline DNAm using robust linear models, and a mixed linear model was performed to investigate DNAm changes over time. Downstream analyses included identifying differentially methylated regions (DMRs) and overrepresented Gene Ontology (GO) Terms. A total of 120 CpG sites and four DMRs were associated with cortisol reactivity, with chromatin modifiers among the top findings. Longitudinal epigenome-wide changes were observed at 32 CpG sites and four DMRs. Overrepresented GO terms were related to learning, cognition, and synaptic processes. Two thyroid-related genes, TTR and TSHR , were observed among the top hits. These findings highlight the association between acute stress and DNAm, suggesting DNAm levels to be related to cortisol reactivity and acute stress to influence DNA methylation patterns dynamically. Key genes involved in thyroid function and transcriptional regulation were implicated in the stress response. Further research with larger samples and multi-omics approaches is needed to confirm these findings, assess their long-term stability, and explore their functional relevance.
Year:
2026
Year:
2026
Structural and functional alterations in the brain’s reward circuitry are present in cocaine use disorder (CocUD), but their molecular underpinnings remain unclear. To investigate these mechanisms, we performed single-nuclei multiome profiling on postmortem caudate nucleus tissue from six individuals with CocUD and eight controls. We profiled 30,030 nuclei, identifying 13 cell types including D1- and D2-medium spiny neurons (MSNs) and glial cells. We observed 1485 differentially regulated genes and 10,342 differentially accessible peaks, with alterations in MSNs and astrocytes related to neurotransmitter activity and synapse organization. Gene regulatory network analysis identified transcription factors including ZEB1 as exhibiting distinct CocUD-specific subclusters, activating downstream expression of ion- and calcium-channels in MSNs. Further, PDE10A emerged as a potential drug target, showing conserved effects in a rat model. This study highlights cell type-specific molecular alterations in CocUD and provides targets for further investigation, demonstrating the value of multi-omics approaches in addiction research.
Year:
2025
Year:
2025
Despite extensive research on DNA methylation (DNAm) signatures associated with alcohol use disorder (AUD), findings are often inconsistent and not replicated. We conducted a large-scale meta-analysis of epigenome-wide association studies (EWAS) to identify reliable, reproducible epigenetic markers of AUD. Seven cohorts, comprising 3,775 individuals (1,325 with AUD), contributed to this meta-analysis within the framework of the Psychiatric Genomics Consortium Substance Use Disorders Epigenetics Working Group. Downstream analyses included the identification of differentially methylated regions, overrepresentation analyses, and the construction of a methylation risk score (MRS). We identified 118 significant CpG sites associated with AUD, with the strongest association found at cg24889777 ( p =5.12×10 -17 ) in the long non-coding RNA LOC100505942. CpG sites were enriched for pathways related to GTPase signaling and transmembrane transporter activity, as well as EWAS signals of alcohol consumption. The MRS explained 10.44% of variance in heavy drinking in an independent cohort (N=2,534, AUC=0.657). This large-scale meta-analysis offers key insights into the epigenetic mechanisms of AUD and lays the groundwork for future research on methylation risk scores for the diagnosis, prognosis, and treatment in AUD.
Year:
2025
Background Alcohol use disorder (AUD) is associated with increased mortality and morbidity risk. A reason for this could be accelerated biological aging, which is strongly influenced by disease processes such as inflammation. As recent studies of AUD show changes in DNA methylation and gene expression in neuroinflammation‐related pathways in the brain, biological aging represents a potentially important construct for understanding the adverse effects of substance use disorders. Epigenetic clocks have shown accelerated aging in blood samples from individuals with AUD. However, no systematic evaluation of biological age measures in AUD across different tissues and brain regions has been undertaken. Methods As markers of biological aging (BioAge markers), we assessed Levine's and Horvath's epigenetic clocks, DNA methylation telomere length (DNAmTL), telomere length (TL), and mitochondrial DNA copy number (mtDNAcn) in postmortem brain samples from Brodmann Area 9 (BA9), caudate nucleus, and ventral striatum ( N = 63–94), and in whole blood samples ( N = 179) of individuals with and without AUD. To evaluate the association between AUD status and BioAge markers, we performed linear regression analyses while adjusting for covariates. Results The majority of BioAge markers were significantly associated with chronological age in all samples. Levine's epigenetic clock and DNAmTL were indicative of accelerated biological aging in AUD in BA9 and whole blood samples, while Horvath's showed the opposite effect in BA9. No significant association of AUD with TL and mtDNAcn was detected. Measured TL and DNAmTL showed only small correlations in blood and none in brain. Conclusions The present study is the first to simultaneously investigate epigenetic clocks, telomere length, and mtDNAcn in postmortem brain and whole blood samples in individuals with AUD. We found evidence for accelerated biological aging in AUD in blood and brain, as measured by Levine's epigenetic clock, and DNAmTL. Additional studies of different tissues from the same individuals are needed to draw valid conclusions about the congruence of biological aging in blood and brain.
Year:
2024
Background The use of mobile devices to continuously monitor objectively extracted parameters of depressive symptomatology is seen as an important step in the understanding and prevention of upcoming depressive episodes. Speech features such as pitch variability, speech pauses, and speech rate are promising indicators, but empirical evidence is limited, given the variability of study designs. Objective Previous research studies have found different speech patterns when comparing single speech recordings between patients and healthy controls, but only a few studies have used repeated assessments to compare depressive and nondepressive episodes within the same patient. To our knowledge, no study has used a series of measurements within patients with depression (eg, intensive longitudinal data) to model the dynamic ebb and flow of subjectively reported depression and concomitant speech samples. However, such data are indispensable for detecting and ultimately preventing upcoming episodes. Methods In this study, we captured voice samples and momentary affect ratings over the course of 3 weeks in a sample of patients (N=30) with an acute depressive episode receiving stationary care. Patients underwent sleep deprivation therapy, a chronotherapeutic intervention that can rapidly improve depression symptomatology. We hypothesized that within-person variability in depressive and affective momentary states would be reflected in the following 3 speech features: pitch variability, speech pauses, and speech rate. We parametrized them using the extended Geneva Minimalistic Acoustic Parameter Set (eGeMAPS) from open-source Speech and Music Interpretation by Large-Space Extraction (openSMILE; audEERING GmbH) and extracted them from a transcript. We analyzed the speech features along with self-reported momentary affect ratings, using multilevel linear regression analysis. We analyzed an average of 32 (SD 19.83) assessments per patient. Results Analyses revealed that pitch variability, speech pauses, and speech rate were associated with depression severity, positive affect, valence, and energetic arousal; furthermore, speech pauses and speech rate were associated with negative affect, and speech pauses were additionally associated with calmness. Specifically, pitch variability was negatively associated with improved momentary states (ie, lower pitch variability was linked to lower depression severity as well as higher positive affect, valence, and energetic arousal). Speech pauses were negatively associated with improved momentary states, whereas speech rate was positively associated with improved momentary states. Conclusions Pitch variability, speech pauses, and speech rate are promising features for the development of clinical prediction technologies to improve patient care as well as timely diagnosis and monitoring of treatment response. Our research is a step forward on the path to developing an automated depression monitoring system, facilitating individually tailored treatments and increased patient empowerment.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Collaborators (35)
Alicia Smith
Professor
Emory University
Renato Polimanti
Yale University School of Medicine
Consuelo Walss‐Bass
Professor and John S. Dunn Foundation Distinguished Chair
The University of Texas Health Science Center at Houston
Alisha Silvia Mercedes Hall
Aarhus University
Brenda WJH Penninx
Professor
-
Eva Friedel
Freie Universität Berlin
Daniel Levey
Assistant Professor
Yale University
Rainer Spanagel
-
Markus Nöthen
Professor, Director
University Hospital Bonn
Fabian Streit
Central Institute of Mental Health
Nikki Copeland
University of Lancaster
Andreas Reif
Chair
Goethe University Frankfurt
Rodrigo Grassi-Oliveira
Full Professor of Neuropsychiatry
Aarhus University
Ian R. Gizer
University of Missouri
Karolina Aberg
Virginia Commonwealth University
John Hettema
Professor
Texas A&M University
Eric Zillich
Ruprecht-Karls-Universität Heidelberg Medizinische Fakultät Mannheim
Diego E. Andrade-Brito
Heidelberg University
Naguib Mechawar
Professor
McGill University
Gustavo Turecki
Chair
McGill University
Joel Gelernter
Professor
Yale University School of Medicine
Marcella Rietschel
Head of department
-
Franz Vollenweider
Chief Psychiatrist, Co-Director, Psychiatric Research Center
University of Zurich
Negar Fani
Associate Professor
Emory University School of Medicine
Eloise Kok
University of Helsinki
Shizhong Han
Lead Investigator
Johns Hopkins University School of Medicine
G. Sutherland
Professor
University of Sydney
Bru Cormand
Professor of Genetics
University of Barcelona
Bradley Webb
Assistant Professor
Virginia Commonwealth University
Laura J Bierut
Alumni Endowed Professor
Washington University in Saint Louis School of Medicine
Marcus Herdener
University of Zurich
Shaunna Clark
Associate Professor
Texas A&M University
Rachel McMahan
Associate Professor
University of Colorado Anschutz Medical Campus
Seyma Katrinli
Assistant Professor
Emory University
Miriam Schiele
Full Professor and Chair
Technische Universität Dresden
Make your next move.
Prepare your application
Review drafts before you send them.